Xponance Inc. boosted its stake in RadNet, Inc. (NASDAQ:RDNT – Free Report) by 5.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 5,010 shares of the medical research company’s stock after purchasing an additional 239 shares during the period. Xponance Inc.’s holdings in RadNet were worth $249,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of RadNet by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 7,425,218 shares of the medical research company’s stock worth $518,577,000 after purchasing an additional 71,910 shares during the last quarter. RTW Investments LP raised its holdings in shares of RadNet by 9.4% in the fourth quarter. RTW Investments LP now owns 1,978,582 shares of the medical research company’s stock valued at $138,184,000 after buying an additional 169,978 shares during the last quarter. Invesco Ltd. raised its holdings in shares of RadNet by 4.3% in the fourth quarter. Invesco Ltd. now owns 1,731,074 shares of the medical research company’s stock valued at $120,898,000 after buying an additional 70,673 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of RadNet by 14.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,689,275 shares of the medical research company’s stock valued at $85,511,000 after buying an additional 213,280 shares during the last quarter. Finally, Hood River Capital Management LLC raised its holdings in shares of RadNet by 3.1% in the fourth quarter. Hood River Capital Management LLC now owns 1,322,879 shares of the medical research company’s stock valued at $92,390,000 after buying an additional 39,881 shares during the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.
Insider Activity at RadNet
In other RadNet news, EVP Alma Gregory Sorensen sold 55,000 shares of the company’s stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $56.48, for a total transaction of $3,106,400.00. Following the completion of the sale, the executive vice president directly owned 1,160,509 shares in the company, valued at $65,545,548.32. This represents a 4.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Norman R. Hames sold 5,536 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $60.00, for a total transaction of $332,160.00. Following the sale, the chief operating officer owned 249,183 shares of the company’s stock, valued at $14,950,980. This trade represents a 2.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 63,447 shares of company stock worth $3,613,220. Company insiders own 5.60% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Analysis on RDNT
RadNet Stock Down 2.3%
RDNT stock opened at $57.49 on Friday. RadNet, Inc. has a 52-week low of $45.00 and a 52-week high of $93.65. The company’s 50 day simple moving average is $57.29 and its 200-day simple moving average is $56.96. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.01 and a quick ratio of 2.01. The firm has a market capitalization of $4.31 billion, a P/E ratio of -133.69 and a beta of 1.41.
RadNet Profile
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Read More
- Five stocks we like better than RadNet
- Pros And Cons Of Monthly Dividend Stocks
- PepsiCo Bottomed Out—Time to Chugalug This Blue-Chip Buy?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- These 3 Rare Earth Stocks Are Surging Alongside MP Materials
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.